Market Overview:
The global Edaravone market is projected to reach at a high CAGR during the forecast period from 2024 to 2031. Edaravone, primarily used to treat amyotrophic lateral sclerosis (ALS), is administered intravenously to help slow the progression of this neurodegenerative disease.
Market Trends:
The growth of the edaravone market is significantly driven by FDA approvals for its use...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian